Visit-to-Visit Variability in Blood Pressure Is Related to Late-Life Cognitive DeclineNovelty and Significance by Qin, Bo et al.
VISIT-TO-VISIT VARIABILITY IN BLOOD PRESSURE IS RELATED 
TO LATE-LIFE COGNITIVE DECLINE
Bo Qina,b, Anthony J. Vierac, Paul Muntnerd, Brenda L. Plassmane, Lloyd J. Edwardsf, 
Linda S. Adaira, Barry M. Popkina, and Michelle A. Mendeza
aDepartment of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC
bDepartment of Population Science, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
cDepartment of Family Medicine and Hypertension Research Program, University of North 
Carolina at Chapel Hill, Chapel Hill, NC
dDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL
eDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, 
NC
fDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC
Abstract
The association between visit-to-visit variability of blood pressure (BP) and cognitive decline over 
time remains incompletely understood in a general population of older adults. We assessed the 
hypothesis that higher visit-to-visit variability in BP, but not mean BP, would be associated with 
faster decline in cognitive function among community-dwelling older adults. This prospective 
cohort study comprised 976 adults who had 3 or 4 visits with BP measurements as part of the 
China Health and Nutrition Survey from 1991, up to their first cognitive tests, and completed 
cognitive screening tests at 2 or more visits in 1997, 2000 or 2004. Visit-to visit BP variability was 
expressed as the standard deviation (SD), coefficient of variation or as the variation independent of 
mean BP across visits conducted at a mean interval of 3.2y. Mean (SD) age at the first cognitive 
test was 64 (6)y. Using multivariable-adjusted linear mixed-effects models, we found higher visit-
to-visit variability in systolic BP, but not mean systolic BP, was associated with a faster decline of 
cognitive function (adjusted mean difference [95% CI] for high vs. low tertile of SD variability: 
standardized composite scores −0.038 standardized units (SU)/y [−0.066, −0.009] and verbal 
memory −0.041 SU/y [−0.075 to −0.008]). Higher visit-to-visit variability in diastolic BP was 
associated with a faster decline of cognitive function, independent of mean diastolic BP, among 
adults 55–64y but not those ≥ 65y. Our results suggest that higher long-term BP visit-to-visit 
variability is associated with a faster rate of cognitive decline among older adults.
*Corresponding author: Michelle A. Mendez, Carolina Population Center, CB # 8120, Chapel Hill, NC 27599, Phone: 919-962-6101; 





Hypertension. Author manuscript; available in PMC 2017 July 01.
Published in final edited form as:














Blood pressure; hypertension; cognition; aging; longitudinal studies
Introduction
Research relating blood pressure (BP) to cognitive disorders has focused on hypertension 
and mean BP levels. Although evidence demonstrates that midlife hypertension is a risk 
factor for cognitive decline, its association with late-life hypertension is less clear.
1
 In 
addition, randomized clinical trials have not shown a consistent effect of BP-lowering 




The clinical relevance of visit-to-visit BP variability has been dismissed until recently. Over 
the past 5 years evidence has accumulated that visit-to-visit BP variability may not be a 
random phenomenon or simply an unimportant measurement artifact, but may instead 
provide information on pathological process and be relevant for prognosis.
3, 4 Recent studies 
have found higher visit-to-visit BP variability, over monthly or yearly visits, to be a strong 
risk factor for stroke,
4
 and of small and larger vessel cerebrovascular diseases,
5, 6 which 
could lead to a cascade of changes related to cognitive decline and dysfunction.
7
Limited research has examined the relationship between visit-to-visit BP variability and 
cognitive function, and the studies that have been conducted relied primarily on 
measurement of cognition at only one timepoint. Previous studies have found higher visit-to-
visit BP variability to be associated with lower cognitive scores in populations taking a high 
number of BP-lowering drugs and other medications. Subjects were at a high risk of 
cardiovascular disease or a high prevalence of hypertension,
8–10 or more than half of the 
samples were cognitively impaired.
11
 It remains uncertain whether visit-to-visit variability 
in BP is associated with a faster rate of cognitive decline in a general population of older 
adults. Using repeated measures of cognition, the current study examined the association 
between visit-to-visit variability in BP and cognitive decline among a sample of community-
dwelling Chinese men and women.
Methods
Subjects
China Health and Nutrition Survey (CHNS) is an ongoing longitudinal open cohort study 
established in 1989. A multistage, random cluster process was used to draw the sample from 
nine provinces of China.
12
 In each wave of the CHNS, demographic, socioeconomic, 
lifestyle, and health information were collected. In 1997, 2000 and 2004, CHNS 
administered cognitive measures among participants 55 years or older, all of whom were 
community dwellers. Among 2,408 adults participated in a cognitive screening test 
(participation rate 73%), 1,677 had at least two measurement occasions of cognitive 
function. Among them, a total of 976 participants also had three or more waves of 
measurement of blood pressure (N=721 and 255 for three and four measures) at or before 
their first cognitive test. The temporal sequence of the assessment of blood pressure and 
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cognitive function is shown in Supplemental Figure 1. Participants not included in the 
analytic sample were similar to those included regarding age, gender, antihypertensive 
treatment, and baseline systolic blood pressure (130.7 mm Hg and 128.9 mm Hg, 
respectively; P=0.07), but had slightly higher diastolic blood pressure (82.1 mm Hg and 80.5 
mm Hg, respectively; P=0.01).
All participants in CHNS provided written informed consent. The institutional review 
committees of the University of North Carolina at Chapel Hill and the National Institute of 
Nutrition and Food Safety, Chinese Center for Disease Control and Prevention, approved 
this study.
Assessments
Assessment of Cognitive Function—Cognitive screening items measured by CHNS in 
face-to-face interviews were derived from part of the Telephone Interview for Cognitive 
Status –modified (TICS-m).
13
 Similar to the Mini–Mental State Examination, TICS-m is 
able to detect cognitive decline over time,
13, 14 which has been used by population based 
studies including the Chinese population.
15, 16 In three waves (1997, 2000 and 2004), CHNS 
used identical cognitive screening items, including immediate and delayed recall of a 10-
word list, counting backward from 20, serial 7 subtraction, and orientation. Both immediate 
and delayed recall scored from 0 to 10. Counting backward and serial 7’s scored from 0 to 7 
and was used to assess attention and calculation. Orientation, with scores ranging from 0 to 
3, was assessed by asking the current date (1 point each for year, month and date). Naming 
the tool usually used to cut paper was given 1 point. Higher scores on all items indicate 
better cognitive function.
Repeated measures of cognitive tests across waves were summarized as outcomes using 
three approaches: 1) a global composite cognitive score, which was the total of all cognitive 
screening items with scores ranging from 0 to 31 points; 2) a standardized composite score 
(in standardized units [SU]), created as an alternative global cognitive measure by averaging 
z-scores of verbal memory and the other items assessing attention, calculation and 
orientation; and 3) verbal memory scores (also in SU) which summarized scores for 
immediate and delayed recall of a 10-word list.
Blood Pressure Measurements—The same standard procedure and calibrated mercury 
sphygmomanometers were used for measuring BP in each wave since 1991. Detailed blood 
pressure measurement methods have been described elsewhere.
17
 Blood pressure was 
measured after a 5-minute seated rest by certified health workers or nurses who had passed a 
comprehensive reliability test. In each wave, three BP measurements were taken with a 30-
second interval between cuff inflations and were averaged to derive the BP for that wave. To 
reduce potential concerns about reverse causation (e.g. blood pressure fluctuated due to 
stresses related to cognitive change), we used blood pressure measurements from 1991 
through the first assessment of cognitive function (1997 or 2000).
For systolic and diastolic blood pressure, separately, we calculated the long-term mean, and 
BP variability across visits. Consistent with a number of other studies,
4, 9, 11, 18–21 visit-to-
visit BP variability was expressed as standard deviation (SD), coefficient of variation (CV), 
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and variation independent of mean (VIM = SD/meanx, with x derived from curve fitting). 
Given the time interval between BP measurements, we also fitted a regression line for each 
participant to separate the two components of total BP variation: model variation and 
residual variation.
Statistical analysis
Two sets of analyses were performed: the analysis for visit-to-visit variability of systolic 
blood pressure (SBP) is described below with an identical approach followed for the analysis 
of visit-to-visit variability of diastolic blood pressure (DBP).
Characteristics of participants were calculated by tertile of SD of SBP. We used linear 
mixed-effects models to evaluate the association between SD of SBP and cognitive status 
over time with the lowest tertile of SD of SBP as the referent. The intercept and slope were 
fitted with random-effects components to account for inter-individual differences in baseline 
and rate of change of cognitive function. The first model adjusted for age, gender, education 
(highest level of education attained primary vs. less), time (year since baseline), and time 
interactions with the above covariates. The second model additionally adjusted for covariates 
considered as potential confounders or change in the effect estimate by ≥10%: urbanization 
index (a multicomponent continuous scale),
22
 ever smoking (yes/no), physical activity 
(tertile), antihypertensive treatment (self-report), mean SBP, and their time interactions. 
Linear trends were tested by modeling the median value of each tertile as a continuous 
variable.
Analyses were repeated modeling tertile of CV and VIM of SBP, as well as separate models 
exploring associations between cognitive decline and tertile of mean SBP (omitting mean 
SBP as a covariate) rather than BP variability. Since SBP increases with age, which can also 
lead to a large standard deviation of SBP, we evaluated if change in SBP over time 
(SBPlast visit-SBPfirst visit) was associated with cognitive function over time. The associations 
between SBP model variation or residual variation with cognitive decline were also 
evaluated.
We examined if the relationship between SD of SBP and cognitive decline was modified by 
one key factor, age, since previous evidence suggested a stronger association between BP 
and cognitive function in midlife vs. later-life.
1
 We also examined if the associations may be 
different between those with vs. without hypertension (defined as measured mean SBP/DBP 
≥140/90 mm Hg or self-reported use of antihypertensive medications) by testing statistical 
interactions using product terms. A P-value<0.1 was defined as statistical significance for 
interaction, while P<0.05 was used for main effects.
To assess the robustness of the findings, first we evaluated if the associations between SBP 
variability and cognitive decline were independent of the remote SBP (i.e. the first BP 
measurement), baseline SBP (i.e. the latest measure at or before cognitive assessment), or 
baseline hypertension status. Second, we repeated the main analyses between visit-to-visit 
BP variability and change in cognitive scores excluding participants who took 
antihypertensive medications (N=113), or who reported a history of MI, stroke or diabetes 
(N=51). Moreover, we repeated the main analyses among a total of 1,213 participants who 
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had at least two waves of measurement of blood pressure (N=237, 721, 255 for two, three 
and four measures). All statistical analyses were performed using STATA (version 11.2; 
STATA Corp LP).
Results
Relationship between visit-to-visit variability in SBP and cognitive decline
Among all participants in the analytical sample, older age, higher urbanization index, lower 
education and physical activity, having a history of stroke and diabetes, and taking 
antihypertensive medication were associated with higher SD of SBP (Table 1). Also, mean 
SBP was progressively higher with increased SD of SBP (r=0.33).
The mean follow-up time for estimating cognitive decline was 5.3 years. Mean SBP was not 
associated with the rate of cognitive change, while higher visit-to-visit variability of SBP 
was associated with a faster decline of cognitive function. Compared to the lowest tertile of 
SD of SBP, the unadjusted rate of global cognitive decline associated with the middle and 
the highest tertile was faster by −0.13 points per year (95% CI: −0.33, 0.07) and −0.26 
points per year (95% CI: −0.45, −0.06) respectively (P-trend=0.01). Visit-to-visit variability 
of SBP remained associated with a faster decline of cognitive function after adjustment for 
age, gender, and education or further adjustment for urbanization index, ever smoking, 
physical activity, antihypertensive treatment, and mean SBP (Figure 1; Table 2). Results 
were consistent for CV and VIM (SD/mean1.4) of SBP.
We did not find a significant association between change in SBP [mean change between the 
first and last visit 8.4 (SD 21.5) mm Hg] and global cognitive decline [Tertile (T)3 vs. T1: 
β=−0.13, 95% CI: −0.33, 0.06, P=0.09). After fitting a regression line from BP 
measurements over time, on average, model variation explained 51% of total variation. 
Greater model variation and residual variation of SBP were both associated with faster rate 
of cognitive decline (Supplemental Table 1).
The associations between visit-to-visit variability in SBP and cognitive decline were not 
modified by age. For example, compared to the lowest tertile of SD of SBP, the unadjusted 
rate of global cognitive decline associated with the highest tertile was different by −0.18 
points per year (95% CI: −0.42, 0.07) among those 55–64 years and by −0.32 points per year 
(95% CI: −0.64, −0.01) among ≥65 years. The results were not modified by baseline 
hypertension status and sociodemographic characteristics such as gender and education. The 
associations remained unchanged after adjusting for remote SBP, baseline SBP, or baseline 
hypertension status. Limiting the analyses to participants who did not take antihypertensive 
medications, or who did not report a history of MI, stroke, or diabetes at baseline did not 
appreciably alter our results. Results materially remained the same in analyses including 
participants with two or more waves of measurement of blood pressure (N=1,213; 
Supplemental Table 2).
Relationship between visit-to-visit variability in DBP and cognitive decline
Since age significantly modified the association between DBP variability and cognitive 
decline (P=0.01), all subsequent analyses for DBP were stratified by age 55–64 (N=610), 
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and ≥65 years (N=366). Increasing tertiles of SD of DBP were associated with higher mean 
DBP and antihypertensive medication in both age groups, and history of MI among 
participants aged ≥65 (Supplemental Table 3). The correlation between mean DBP and SD 
of DBP was r=0.14 among participants <65y and r=0.09 for those ≥65y.
Among adults aged less than 65 years, the unadjusted annual rate of cognitive decline was 
faster by −0.27 points (95% CI: −0.51, −0.03) and −0.27 points (95% CI: −0.51, −0.03) for 
the middle and the highest tertile of SD of DBP (P-trend=0.03). These associations 
persistent in age, gender-, education- adjusted and multivariate adjusted models (Figure 2; 
Supplemental Table 4). Results were consistent for CV and VIM of DBP, but no significant 
rate difference was found for verbal memory scores. On average, model variation explained 
46% of total variation in DBP. No significant difference in global cognitive decline was 
associated with model variation (T3 vs. T1: β=−0.14, 95% CI: −0.38, 0.11; P-trend=0.45), 
but a difference was observed in association with the residual variation of DBP (T3 vs. T1: 
β=−0.27, 95% CI: −0.51, −0.03; P-trend=0.04) suggesting the relation between visit-to-visit 
DBP variability and cognitive decline is possibly due to the DBP fluctuation instead of the 
systematic pattern over time. SD, CV, or VIM of DBP was not associated with rates of 
cognitive decline for participants 65 years and older.
The associations between visit-to-visit variability in DBP remained unchanged for both age 
groups with additional adjustment for remote DBP, baseline DBP, or baseline hypertension 
status, or limited the analyses to participants who did not take antihypertensive medications 
or who did not report a history of MI, stroke, or diabetes. The associations between DBP 
variability and cognitive decline were not altered if analyses were modified to include 
participants with two or more waves of measurement of blood pressure, rather than three or 
more (Supplemental Table 5).
Discussion
In a cohort of community dwelling Chinese older adults, higher visit-to-visit variability in 
SBP was associated with a faster decline of global cognitive function and verbal memory 
over a mean follow-up of 5 years. Higher visit-to-visit DBP variability was associated with a 
faster decline of global cognitive function among adults 55–64 years of age. In contrast, we 
did not observe an association between mean SBP or DBP and cognitive change over time.
Few studies have evaluated the association between visit-to-visit BP variability and cognitive 
function. The results of our analyses are consistent with previous studies suggesting that 
long-term BP variability may be more informative than mean BP in predicting cognitive 
function in older adults.
8–11 Our definition of visit-to-visit BP variability which used the SD, 
CV and VIM of measures at each time point, is consistent with previous studies.
9–11, 18–20 In 
earlier studies, the interval between each BP visit ranged from one month to up to four 
years; the mean interval in our study was 3.2 years. In a US study, where more than half of 
the participants had cognitive impairment, visit-to-visit variability of SBP, but not DBP, was 
associated with worse episodic memory, executive and global cognitive function.
11
 In other 
studies where participants were at high risk of cardiovascular disease at entry, visit-to-visit 
SBP variability was associated with lower cognitive scores.
8–10 One of these studies found 
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both DBP and SBP variability were associated with cortical infarcts and lower hippocampal 
volume among a subgroup with magnetic resonance imaging (MRI) showed.
9
 Moreover, 
recent studies found higher visit-to-visit variability in both SBP and DBP among AD 
patients,
19
 and with higher incidence of dementia among participants 65+ years in which 
60% were hypertensive at entry.
20
 Most of the previous studies were conducted among 
participants with high prevalence of BP-lowering treatments and other medication use. In 
contrast, our sample had an initial 22% prevalence of hypertension based on measured BP 
(mainly in 1991) and much lower level of diagnosis (7%) and treatment (4%), providing a 
less selective sample and a more natural study of the impact of visit-to-visit BP variability.
All of the above studies demonstrated that these associations were independent of mean BP. 
In fact, as in our data, very few of them found a significant relation between mean BP and 
cognitive outcomes. Consistent with these findings, clinical trials aimed at lowering BP to 
reduce the incidence of dementia
1
 or cognitive decline
2
 have not shown a consistent result. 
However, it is noteworthy that in the Syst-Eur trial, calcium-channel blockers were found to 
reduce the incidence of dementia,
23
 and separate studies have shown calcium-channel 
blockers to be most effective for reducing variability of BP among all antihypertensive drug 
classes.
24
In the current study, while benefits of lower variability in SBP were observed for the full 
sample, we found that the association between DBP variability and cognitive decline was 
stronger at younger ages. We hypothesize that this may be due to fewer competing causes of 
cognitive disorders. Similar to our finding regarding the role of age, Rothwell and others 
found that BP variability, though increasing with age, was more predictive of stroke risk for 
younger than for older patients.
4
 Our findings of a null association between DBP variability 
and cognitive decline for adults aged 65 years and older were consistent with several other 
studies,
8, 9 while our observations among adults below 65 years need to be confirmed by 
other studies.
Current treatment decisions for high BP are based on the mean value, which are typically 
assessed over several visits. 
25
 However, recent findings suggest that variability of monthly 
or yearly BP measures predict the risk of stroke,
4
 cardiovascular morbidity and mortality,
26 
and overall mortality independent of mean BP.
18
 Our study adds to the evidence that long-
term BP variability is also relevant to cognitive functioning in older adults.
Potential mechanisms linking visit-to-visit BP variability and impaired cognitive function 
have been proposed. First, MRI findings support the hypothesis that the peripheral BP 
fluctuations could lead to cerebral hypoperfusion and silent vascular brain lesions,
5, 6, 9 
which in turn increase the risk of cognitive deterioration.
27, 28 These studies have found that 
higher visit-to-visit BP variability, based on BP measurements during 3 study visits at 1 to 3-
year intervals, was related to white matter hyperintensities or lesions,
5, 6 and a recent study 
with visits at 3-months intervals found visit-to-visit BP was associated with decreased 
hippocampal volume, cerebral microbleeds and cortical infarcts.
9
 Second, it is also possible 
that higher BP variability may represent an augmented hemodynamic instability, which 
could lead to the damage of microvasculature with changes in brain structure and function.
29 
Consistent with this notion, higher BP variability was associated with endothelial injury and 
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 It is hypothesized that cerebral microcirculatory endothelial dysfunction may 
influence the integrity of the blood-brain barrier, cerebral auto-regulation and other 
physiologic processes, with subsequent impact on the genesis of brain infarcts and the 
development of cognitive impairment.
31
A number of limitations of the current study should be considered. First, although a wide 
array of covariates were adjusted in the model, measures of potential confounders (e.g., 
depression, heart rate) were not available, and some residual confounding is possible. 
Second, BP for a given participant was not systematically assessed at the same time of day 
across the multiple follow-ups which could contribute to the random error of BP variability 
and attenuated the associations. Third, like some other studies,
18, 20 BP variability in our 
study was calculated from 3 or 4 visits, which has limited the precision and reproducibility 
of estimating BP variability compared to more measurements. In addition, only 58% of 
participants were eligible for main analysis due to the open cohort design, but selection bias 
was not a strong concern given the similar findings when more participants were included in 
the sensitivity analysis. The relatively narrow scope of cognitive screening items adopted in 
CHNS is another limitation. The association between BP variability and cognitive decline 
may be strengthened if more sensitive tools for cognitive screening were available.
Perspectives
The current study supports the hypothesis that higher long-term BP variability independent 
of mean BP is associated with a faster rate of cognitive decline among older adults. 
Controlling BP instability could possibly be a strategy in preserving cognitive function 
among older adults, but intervention trials and more longitudinal studies are needed to 
confirm this finding.
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• Utilizing repeated measures of cognitive function, this prospective study shows 
that higher long term visit-to-visit variability in systolic blood pressure, but not 
mean blood pressure, is associated with faster rate of cognitive decline in 
community dwelling older adults.
• The association between visit-to-visit variability in diastolic blood pressure and 
cognitive decline is age-dependent: higher visit-to-visit variability in diastolic 
blood pressure was associated with a faster decline of cognitive function among 
adults < 65 years but not those ≥ 65 years.
What is Relevant?
• The present study suggests that controlling blood pressure instability could be a 
potential strategy in preserving cognitive function among older adults.
Summary
• In a cohort of community dwelling older adults, higher visit-to-visit variability 
in systolic blood pressure was associated with a faster decline of global 
cognitive function and verbal memory. Higher visit-to-visit diastolic blood 
pressure variability was associated with a faster decline of global cognitive 
function among adults 55–64 years. Mean SBP or DBP was not associated with 
cognitive change.
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Mean difference in rate of change in global cognitive scores, composite scores, and verbal 
memory scores by tertiles of mean, SD, CV or VIM of SBP. Values presented in Figure 1 are 
presented in Table 2 (model 2). CV, coefficient of variation; SBP, systolic blood pressure; 
SD, standard deviation; SU, standard unit; VIM, variation independent of mean.
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Mean difference in rate of change in global cognitive scores, composite scores, and verbal 
memory scores by tertiles of mean DBP and standard deviation of DBP among different age 
groups. Values presented in Figure 2 are presented in Supplemental Table 4 (model 2). Age 
significantly modified the association between standard deviation of DBP and change in 
global cognitive scores (P=0.01). SD, standard deviation; SU, standard unit.
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Table 1
Participant characteristics by tertile of standard deviation in SBP








Age, y 62.2 (6.3) 63.1 (6.9) 64.8 (6.9) <0.001
Women, % 51.1 52.2 52.0 0.15
North region, % 25.7 30.1 22.6 0.59
Mean urbanization index 47.9 (16.5) 49.6 (15.8) 51.2 (16.5) 0.05
Graduated from primary or above, % 40.7 45.4 34.1 0.005
Ever smoking, % 46.2 47.6 47.1 0.52
Mean physical activity, %
 Low tertile 27.2 32.5 36.8 Ref
 Middle 33.6 29.8 32.5 0.19
 High 39.1 37.7 30.7 0.04
Mean body mass index, kg/m2 22.0 (2.8) 22.4 (3.1) 22.2 (3.4) 0.14
History of myocardial infarction, % † 0.9 1.2 1.9 0.46
History of stroke, % † 0.9 1.2 3.7 0.01
History of diabetes, % † 1.2 2.2 3.4 <0.001
Mean SBP, mm Hg 119.0 (14.7) 122.4 (15.0) 130.0 (18.0) <0.001
Mean DBP, mm Hg 76.5 (8.9) 78.7 (8.6) 80.1 (9.4) <0.001
Standard deviation of DBP, mm Hg 6.5 (4.1) 8.2 (4.8) 10.3 (5.6) <0.001
Antihypertensive medication, % † 8.0 10.7 16.1 <0.001
Numbers in table are mean (SD) or percentage. DBP, diastolic blood pressure; SBP, systolic blood pressure.
*
Tests for P-trend were based on generalized linear regression with SD of SBP (continuous) as the independent variable.
†
History of myocardial infarction, stroke, diabetes and antihypertensive medication were self-reported information.
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Table 2
Mean difference in rate of change in cognitive scores comparing tertiles of mean SBP, standard deviation, 
coefficient variation and variation independent of mean SBP (N=976)
T1 T2 T3 P-trend
Global scores* mean change: −0.41 points/y
Tertile of mean SBP
<115.22 mm Hg 115.22–128.76 mm Hg ≥128.77 mm Hg
Model 1 0 (ref) 0.09 (−0.10, 0.28) 0.09 (−0.12, 0.29) 0.43
Model 2 0 (ref) 0.09 (−0.10, 0.29) 0.00 (−0.22, 0.22) 0.99
Tertile of Standard Deviation of SBP
<9.30 mm Hg 9.30–15.00 mm Hg ≥15.01 mm Hg
Model 1 0 (ref) −0.13 (−0.33, 0.06) −0.24 (−0.43, −0.04) 0.02
Model 2 0 (ref) −0.13 (−0.33, 0.06) −0.27 (−0.47, −0.07) 0.008
Tertile of Coefficient of Variation of SBP
<7.50% 7.50–12.18% ≥12.19%
Model 1 0 (ref) −0.15 (−0.34, 0.05) −0.31 (−0.51, −0.12) 0.002
Model 2 0 (ref) −0.13 (−0.32, 0.06) −0.31 (−0.50, −0.11) 0.002
Tertile of Variation Independent of Mean SBP
<1.03% 1.04–1.67% ≥1.68%
Model 1 0 (ref) −0.19 (−0.39, 0.00) −0.28 (−0.47, −0.08) 0.005
Model 2 0 (ref) −0.17 (−0.36, 0.02) −0.27 (−0.47, −0.08) 0.006
Composite scores* mean change: −0.062 SU/y
Tertile of mean SBP
Model 1 0 (ref) 0.015 (−0.013, 0.043) 0.010 (−0.020, 0.039) 0.55
Model 2 0 (ref) 0.015 (−0.013, 0.043) −0.001 (−0.033, 0.031) 0.95
Tertile of Standard Deviation of SBP
Model 1 0 (ref) −0.020 (−0.048, 0.008) −0.034 (−0.062, −0.005) 0.02
Model 2 0 (ref) −0.020 (−0.048, 0.008) −0.038 (−0.066, −0.009) 0.01
Tertile of Coefficient of Variation of SBP
Model 1 0 (ref) −0.024 (−0.052, 0.004) −0.045 (−0.073, −0.016) 0.002
Model 2 0 (ref) −0.022 (−0.049, 0.006) −0.044 (−0.072, −0.016) 0.002
Tertile of Variation Independent of Mean SBP
Model 1 0 (ref) −0.030 (−0.058, −0.002) −0.040 (−0.068, −0.012) 0.006
Model 2 0 (ref) −0.027 (−0.055, 0.001) −0.039 (−0.067, −0.011) 0.006
Verbal memory* mean change: −0.051 SU/y
Tertile of mean SBP
Model 1 0 (ref) 0.008 (−0.025, 0.040) 0.020 (−0.014, 0.054) 0.25
Model 2 0 (ref) 0.008 (−0.024, 0.041) 0.005 (−0.032, 0.042) 0.79
Tertile of Standard Deviation of SBP
Model 1 0 (ref) −0.017 (−0.050, 0.016) −0.036 (−0.068, −0.003) 0.03
Model 2 0 (ref) −0.018 (−0.051, 0.015) −0.041 (−0.075, −0.008) 0.02













Qin et al. Page 16
T1 T2 T3 P-trend
Tertile of Coefficient of Variation of SBP
Model 1 0 (ref) −0.013 (−0.045, 0.020) −0.047 (−0.080, −0.014) 0.004
Model 2 0 (ref) −0.010 (−0.043, 0.022) −0.046 (−0.079, −0.013) 0.006
Tertile of Variation Independent of Mean SBP
Model 1 0 (ref) −0.020 (−0.052, 0.012) −0.041 (−0.074, −0.008) 0.01
Model 2 0 (ref) −0.017 (−0.049, 0.016) −0.040 (−0.072, −0.007) 0.02
Numbers in table are mean difference compared with tertile 1 (95% CI) unless otherwise specified. A negative β coefficient indicates faster rate of 
decline in cognitive performance. Model 1 adjusted for age, gender, education, time, and time interactions with each covariate. Model 2 
additionally adjusted for urbanization index, ever smoking, physical activity, ever used antihypertensive treatment, mean SBP for variability 
analysis, and time interactions with each covariate.
*
Global score combined results of immediate recall of a 10-word list, delayed recall of a 10-word list, counting backward from 20, serial 7 
subtraction, and orientation; Composite scores were computed by baseline z scores of memory scores and the rest of the cognitive scores, and were 
averaged into a single measure. Verbal memory score combined results of immediate and delayed recall of a 10-word list.
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